CUA Educational Content

ELEVATE: Optimizing the Use of ARPIs in Castration-Sensitive Prostate Cancer

Speakers: Christian Kollmannsberger, Tony Finelli, Andrew Feifer


  • Understand the efficacy and safety data from randomized controlled trials investigating ADT + ARPI
  • Consider the appropriate treatment course and utilize practical strategies for managing patients diagnosed with mCSPC
  • Apply the Canadian Urological Association guidelines on mCSPC and other decision support tools to clinical practice

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.

This program has received financial support from Astellas in the form of an educational grant.